← Back to Clinical Trials
Recruiting NCT06786702

NCT06786702 The Importance of Preserving the Round Ligament in the Repair of Inguinal Hernias in Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06786702
Status Recruiting
Phase
Sponsor Muhammet Mustafa Vural
Condition Inguinal Hernia
Study Type INTERVENTIONAL
Enrollment 106 participants
Start Date 2024-04-20
Primary Completion 2025-04-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Laparoscopic TAPP (Trans Abdominal Pre-Peritoneal) hernia repair: Round Ligament PreservationLaparoscopic TAPP (Trans Abdominal Pre-Peritoneal) hernia repair: Round Ligament Cutting

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 106 participants in total. It began in 2024-04-20 with a primary completion date of 2025-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to evaluate the impact of preserving or not preserving the round ligament during laparoscopic Trans Abdominal Pre-Peritoneal (TAPP) hernia repair on postoperative outcomes in female patients. Specifically, the study will compare outcomes such as postoperative pain, seroma, hematoma, prolapsus of uterina , recurrence rates, and quality of life between patients whose round ligament was preserved versus those whose ligament was cut.

Eligibility Criteria

Inclusion Criteria: * For patients applying to the General Surgery Clinic of Basaksehir Cam Sakura City Hospital: * Age Range: Female patients aged between 18 and 70 years. * Type of Hernia: Patients with inguinal, direct or indirect, femoral, and obturator hernias. * Surgical Indication: Patients indicated for TAPP (Transabdominal Preperitoneal) surgery. * Consent: Patients who consent to participate in the study. * General Anesthesia: Patients who are suitable for general anesthesia. * Follow-up: Patients who attend follow-up appointments regularly. Exclusion Criteria: * Age: Female patients under 18 years old or over 70 years old. * Surgical Technique: Patients who are operated on with techniques other than TAPP (e.g., TEP, conventional surgery). * Hernia Type: Patients with strangulated or incarcerated hernias. * Hernia Location: Patients with hernias outside the groin region. * Surgical Site: Surgeries performed in different clinics. * Gender: Male patients.

Contact & Investigator

Central Contact

Muhammet M. Vural, M.D

✉ mvural2995@gmail.com

📞 05413637585

Principal Investigator

Muhammet M. Vural, M.D

PRINCIPAL INVESTIGATOR

Basakşehir Çam Sakura Şehir Hastanesi

Frequently Asked Questions

Who can join the NCT06786702 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 70 Years, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06786702 currently recruiting?

Yes, NCT06786702 is actively recruiting participants. Contact the research team at mvural2995@gmail.com for enrollment information.

Where is the NCT06786702 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06786702 clinical trial?

NCT06786702 is sponsored by Muhammet Mustafa Vural. The principal investigator is Muhammet M. Vural, M.D at Basakşehir Çam Sakura Şehir Hastanesi. The trial plans to enroll 106 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology